Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects

Journal of Neuroscience

Volumn 35, Issue 15, 2015, Pages 5990-5997

  Robertson, Chelsea L ^a,c   Ishibashi, Kenji ^a,b,e   Mandelkern, Mark A ^c,d   Brown, Amira K ^b,f   Ghahremani, Dara G ^b   Sabb, Fred ^b,g   Bilder, Robert ^b   Cannon, Tyrone ^a,i   Borg, Jacqueline ^a,h   London, Edythe D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^f CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^g UNIVERSITY OF OREGON   (United States)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ YALE UNIVERSITY   (United States)

Author keywords

Dopamine; Impulsivity; PET imaging

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; 5 (7 BENZOFURANYL) 8 CHLORO 2,3,4,5 TETRAHYDRO 7 HYDROXY 3 METHYL 1H 3 BENZAZEPINE; BENZAMIDE DERIVATIVE; BENZAZEPINE DERIVATIVE; BENZOFURAN DERIVATIVE; FALLYPRIDE; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; COGNITION; CONNECTOME; CONTINUOUS PERFORMANCE TEST; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; RESPONSE INHIBITION; RESPONSE TIME; STOP SIGNAL TASK; STRIATE CORTEX; VENTRAL STRIATUM; CORPUS STRIATUM; DECISION MAKING; DRUG EFFECTS; INHIBITION (PSYCHOLOGY); METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; REGRESSION ANALYSIS; SCINTISCANNING; THREE DIMENSIONAL IMAGING; YOUNG ADULT;

ADULT; BENZAMIDES; BENZAZEPINES; BENZOFURANS; CHOICE BEHAVIOR; CORPUS STRIATUM; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGING, THREE-DIMENSIONAL; INHIBITION (PSYCHOLOGY); MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84929257822     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4850-14.2015     Document Type: Article

References (80)

1. Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M, Anjilvel S, Pidcock J, Guo NN, Lombardo I, Mann JJ, Van Heertum R, Foged C, Halldin C, Laruelle M (2000) Measurement of striatal and ex-trastriatal dopamine DI receptor binding potential with [ 11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab 20:225-243. CrossRef Medline
2. Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266-271. CrossRef Medline
3. Andersen PH, Grønvald FC, Hohlweg R, Hansen LB, Guddal E, Braestrup C, Nielsen EB (1992) NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine DI receptor antagonists. Eur J Pharmacol 219:45-52. CrossRef Medline
4. Aron AR, Dowson JH, Sahakian BJ, Robbins TW (2003) Methylphenidate improves response inhibition in adults with attention-deficit/hyperactiv-ity disorder. Biol Psychiatry 54:1465-1468. CrossRef Medline
5. Aron AR, Robbins TW, Poldrack RA (2014) Inhibition and the right inferior frontal cortex: one decade on. Trends Cogn Sci 18:177-185. CrossRef Medline
6. Band GP, van der Molen MW, Logan GD (2003) Horse-race model simulations of the stop-signal procedure. Acta Psychol (Amst) 112:105-142. CrossRef
7. Bari A, Robbins TW (2013) Noradrenergic versus dopaminergic modulation of im-pulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD. Psychopharmacology (Berl) 230:89-111. CrossRef Medline
8. Bedard AC, Ickowicz A, Logan GD, Hogg-Johnson S, Schachar R, Tannock R (2003) Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. J Abnorm Child Psychol 31:315-327. CrossRef Medline
9. Bilder RM, Sabb FW, Cannon TD, London ED, Jentsch JD, Parker DS, Poldrack RA, Evans C, Freimer NB (2009) Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience 164:30-42. CrossRef Medline
10. Boehler CN, Appelbaum LG, Krebs RM, Hopf JM, Woldorff MG (2010) Pinning down response inhibition in the brain—conjunction analyses of the stop-signal task. Neuroimage 52:1621-1632. CrossRef Medline
11. Broos N, Schmaal L, Wiskerke J, Kostelijk L, Lam T, Stoop N, Weierink L, Ham J, de Geus EJ, Schoffelmeer AN, van den Brink W, Veltman DJ, de Vries TJ, Pattij T, Goudriaan AE (2012) The relationship between impulsive choice and impulsive action: a cross-species translational study. PLoS One 7:e36781. CrossRef Medline
12. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Kessler RM, Zald DH (2010) Dopaminergic network differences in human impulsivity. Science 329:532. CrossRef Medline
13. Chamberlain SR, Müller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2004) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861-863. CrossRef Medline
14. Colzato LS, van den Wildenberg WP, Van der Does AJ, Hommel B (2010) Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 170:782-788. CrossRef Medline
15. Colzato LS, van den Wildenberg WP, Hommel B (2013) The genetic impact (C957T-DRD2) on inhibitory control is magnified by aging. Neuropsychologia 51:1377-1381. CrossRef Medline
16. Colzato LS, Jongkees BJ, Sellaro R, van den Wildenberg WP, Hommel B (2013) Eating to stop: tyrosine supplementation enhances inhibitory control but not response execution. Neuropsychologia 62:398-402. CrossRef Medline
17. Congdon E, Mumford JA, Cohen JR, Galvan A, Canli T, Poldrack RA (2012) Measurement and reliability of response inhibition. Front Psychol 3:37. CrossRef Medline
18. Cox SM, Frank MJ, Larcher K, Fellows LK, Clark CA, Leyton M, Dagher A (2014) Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes. Neuroimage 109:95-101. CrossRef Medline
19. Creese I, Sibley DR, Hamblin MW, Leff SE (1983) The classification of dopamine receptors: relationship to radioligand binding. Annu Rev Neurosci 6:43-71. CrossRef Medline
20. Dailey JW, Mar AC, Economidou D, Robbins TW (2008) Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neuro-chemistry. Pharmacol Biochem Behav 90:250-260. CrossRef Medline
21. de Wit H, Crean J, Richards JB (2000) Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci 114:830-837. CrossRef Medline
22. Dreyer JK, Herrik KF, Berg RW, Hounsgaard JD (2010) Influence of phasic and tonic dopamine release on receptor activation. J Neurosci 30:14273-14283. CrossRef Medline
23. Dunn JT, Clark-Papasavas C, Marsden P, Baker S, Cleij M, Kapur S, Kessler R, Howard R, Reeves SJ (2013) Establishing test-retest reliability of an adapted [ (18)F] fallypride imaging protocol in older people. J Cereb Blood FlowMetab 33:1098-1103. CrossRef Medline
24. Durstewitz D, Seamans JK (2008) The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia. Biol Psychiatry 64:739-749. CrossRef Medline
25. Eagle DM, Baunez C (2010) Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 34:50-72. CrossRef Medline
26. Eagle DM, Robbins TW (2003a) Lesions of the medial prefrontal cortex or nucleus accumbens core do not impair inhibitory control in rats performing a stop-signal reaction time task. Behav Brain Res 146:131-144. CrossRef Medline
27. Eagle DM, Robbins TW (2003b) Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci 117:1302-1317. CrossRef Medline
28. Eagle DM, Tufft MR, Goodchild HL, Robbins TW (2007) Differential effects of modafìnil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) 192:193-206. CrossRef Medline
29. Eagle DM, Bari A, Robbins TW (2008) The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/ no-go tasks. Psychopharmacology (Berl) 199:439-456. CrossRef Medline
30. 2 receptor subtypes in the dor-somedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J Neurosci 31:7349-7356. CrossRef Medline
31. Ekelund J, Slifstein M, Narendran R, Guillin O, Belani H, Guo NN, Hwang Y, Hwang DR, Abi-Dargham A, Laruelle M (2007) In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390. Mol Imaging Biol 9:117-125. CrossRef Medline
32. Fields S, Collins C, Leraas K, Reynolds B (2009) Dimensions of impulsive behavior in adolescent smokers and nonsmokers. Exp Clin Psychophar-macol 17:302-311. CrossRef Medline
33. Fillmore MT, Rush CR (2002) Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend 66:265-273. CrossRef Medline
34. Frank MJ (2005) Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J Cogn Neurosci 17:51-72. CrossRef Medline
35. Frank MJ, Santamaria A, O’Reilly RC, Willcutt E (2007) Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Neuropsychopharmacology 32: 1583-1599. CrossRef Medline
36. Fujita M, Cropley V, Nathan P, Brown A, Sangare J, Ryu Y, Sprague K, Berman K, Pike V, Innis R (2006) Test retest reproducibility and influence of dopamine levels on [18F] fallypride PET quantification. J Nucl Med 47 [Suppl 1]:282P.
37. Gerfen CR, Surmeier DJ (2011) Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34:441-466. CrossRef Medline
38. 3 receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci 32:7316-7324. CrossRef Medline
39. Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L (1994) Distribution of Dl-and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11:245-256. CrossRef Medline
40. 2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15:5222-5237. Medline
41. Ishibashi K, Robertson CL, Mandelkern MA, Morgan AT, London ED (2008) The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region. Mol Imaging 12: 1536-0121. CrossRef Medline
42. Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143-156. CrossRef Medline
43. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17:825-841. CrossRef Medline
44. Jentsch JD, Ashenhurst JR, Cervantes MC, Groman SM, James AS, Pennington ZT (2014) Dissecting impulsivity and its relationships to drug addictions. Ann N Y Acad Sci 1327:1-26. CrossRef Medline
45. Keeler JF, Pretsell DO, Robbins TW (2014) Functional implications of dopamine D1 vs. D2 receptors: a “prepare and select” model of the striatal direct vs. indirect pathways. Neuroscience 282C: 156-175. CrossRef Medline
46. Kreitzer AC, Berke JD (2011) Investigating striatal function through cell-type-specific manipulations. Neuroscience 198:19-26. CrossRef Medline
47. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158. CrossRef Medline
48. Lane SD, Moeller FG, Steinberg JL, Buzby M, Kosten TR (2007) Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty. Am J Drug Alcohol Abuse 33:717-726. CrossRef Medline
49. 3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 29:14734-14740. CrossRef Medline
50. Logan GD, Cowan WB, Davis KA (1984) On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10:276-291. CrossRef Medline
51. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21:1034-1057. CrossRef Medline
52. Mink JW (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50:381-425. CrossRef Medline
53. Monterosso JR, Aron AR, Cordova X, Xu J, London ED (2005) Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 79:273-277. CrossRef Medline
54. Mukheŋee J, Yang ZY, Das MK, Brown T (1995) Fluorinatedbenzamide neuroleptics—ID. Development of (S)-N-[(l-aüyl-2-pyrroÜdinyl)methyl]-5-(3-[ 18F] fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Nucl Med Biol 22:283-296. CrossRef Medline
55. Murray AM, Ryoo HL, Gurevich E, Joyce JN (1994) Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 91:11271-11275. CrossRef Medline
56. Nandam LS, Hester R, Wagner J, Dean AJ, Messer C, Honeysett A, Nathan PJ, Bellgrove MA (2013) Dopamine D(2) receptor modulation of human response inhibition and error awareness. J Cogn Neurosci 25:649-656. CrossRef Medline
57. Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907-922. CrossRef Medline
58. Ramdani C, Carbonnell L, Vidal F, Beranger C, Dagher A, Hasbroucq T (2009) Dopamine precursors depletion impairs impulse control in healthy volunteers. Psychopharmacology (Berl) 232:477-487. CrossRef Medline
59. Reynolds B, Ortengren A, Richards JB, de Wit H (2006) Dimensions of impulsive behavior: personality and behavioral measures. Pers Individ Dif 40:305-315. CrossRef
60. Reynolds B, Penfold RB, Patak M (2008) Dimensions of impulsive behavior in adolescents: laboratory behavioral assessments. Exp Clin Psychophar-macol 16:124-131. CrossRef Medline
61. Robinson ES, Eagle DM, Economidou D, Theobald DE, Mar AC, Murphy ER, Robbins TW, Dailey JW (2009) Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in “waiting” versus “stopping.” Behav Brain Res 196:310-316. CrossRef Medline
62. Rubia K, Russell T, Overmeyer S, Brammer MJ, Bullmore ET, Sharma T, Simmons A, Williams SC, Giampietro V, Andrew CM, Taylor E (2001) Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage 13:250-261. CrossRef Medline
63. Senderecka M, Grabowska A, Szewczyk J, Gere K, Chmylak R (2012) Response inhibition of children with ADHD in the stop-signal task: an event-related potential study. Int J Psychophysiol 85:93-105. CrossRef Medline
64. Slifstein M, Hwang DR, Huang Y, Guo N, Sudo Y, Narendran R, Talbot P, Laruelle M (2004) In vivo affinity of [ 18F]fallypride for striatal and ex-trastriatal dopamine D2 receptors in nonhuman primates. Psychopharmacology (Berl) 175:274-286. CrossRef Medline
65. Slifstein M, Kegeles LS, Gonzales R, Frankie WG, Xu X, Laruelle M, Abi-Dargham A (2007) [ 11C]NNC 112 selectivity for dopamine DI and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects. J Cereb Blood Flow Metab 27:1733-1741. CrossRef Medline
66. Soreni N, Crosbie J, Ickowicz A, Schachar R (2009) Stop signal and Conners' continuous performance tasks: test-retest reliability of two inhibition measures in ADHD children. J Atten Disord 13:137-143. CrossRef Medline
67. Steele VR, Aharoni E, Munro GE, Calhoun VD, Nyalakanti P, Stevens MC, Pearlson G, Kiehl KA (2013) A large scale (N = 102) functional neuro-imaging study of response inhibition in a Go/NoGo task. Behav Brain Res 256:529-536. CrossRef Medline
68. Surmeier DJ, Ding J, Day M, Wang Z, Shen W (2007) DI and D2 dopaminereceptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30:228-235. CrossRef Medline
69. Swick D, Ashley V, Turken U (2011) Are the neural correlates of stopping and not going identical? Quantitative meta-analysis of two response inhibition tasks. Neuroimage 56:1655-1665. CrossRef Medline
70. Tannock R, Schachar RJ, Carr RP, Chajczyk D, Logan GD (1989) Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 17:473-491. CrossRef Medline
71. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD (1998) Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci U S A 95:14494-14499. CrossRef Medline
72. Van Sickle J (2003) Analyzing correlations between stream and watershed attributes. JAWRA 39:717-726. CrossRef
73. Vermeulen RJ, Drukarch B, Sahadat MC, Goosen C, Wolters EC, Stoof JC (1994) The dopamine DI agonist SKF 81297 and the dopamine D2 agonist LY171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys. Mov Disord 9:664-672. CrossRef Medline
74. Weafer J, Baggott MJ, de Wit H (2013) Test-retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention. Exp Clin Psychopharmacol 21:475-481. CrossRef Medline
75. Wöstmann NM, Aichert DS, Costa A, Rubia K, Möller HJ, Ettinger U (2013) Reliability and plasticity of response inhibition and interference control. Brain Cogn 81:82-94. CrossRef Medline
76. Wu Y, Carson RE (2002) Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 22:1440-1452. CrossRef Medline
77. Zald DH, Cowan RL, Riccardi P, Baldwin RM, Ansari MS, Li R, Shelby ES, Smith CE, McHugo M, Kessler RM (2008) Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans. J Neurosci 28:14372-14378. CrossRef Medline
78. Zald DH, Woodward ND, Cowan RL, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Smith CE, Hakyemez H, Li R, Kessler RM (2010) The interrelationship of dopamine D2-like receptor availability in striatal and ex-trastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding. Neuroimage 51:53-62. CrossRef Medline
79. Zheng D, Oka T, Bokura H, Yamaguchi S (2008) The key locus of common response inhibition network for no-go and stop signals. J Cogn Neurosci 20:1434-1442. CrossRef Medline
80. Zheng P, Zhang XX, Bunney BS, Shi WX (1999) Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience 91:527-535. CrossRef Medline